MDR1 gene expression and prognostic factors in primary breast carcinomas. 1991

J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
Clinic for Internal Medicine I, Vienna, Austria.

To prospectively assess the role of the MDR1 gene in breast carcinomas, MDR1 RNA levels of breast carcinoma specimens were determined by slot blot analysis. In 59 evaluable patients with primary breast carcinomas, MDR1 RNA levels of the carcinomas were negative in 54%, low in 29% and high in 17% of the patients. No differences in age, menopause status, oestrogen and progesterone receptor levels, tumour size, lymph node involvement and c-erbB-2/neu gene expression were observed between MDR1 RNA negative patients and MDR1 RNA positive patients.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
July 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
March 1999, Laboratory investigation; a journal of technical methods and pathology,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
September 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
October 1997, European journal of cancer (Oxford, England : 1990),
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
January 1993, Breast cancer research and treatment,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
November 1990, Journal of the National Cancer Institute,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
November 1995, Clinical chemistry,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
August 1993, Acta medica Okayama,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
August 2016, Carcinogenesis,
J Wallner, and D Depisch, and M Hopfner, and K Haider, and J Spona, and H Ludwig, and R Pirker
July 2004, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Copied contents to your clipboard!